Biofortuna Limited, located at 2 Tenth Avenue, Deeside Industrial Park, Deeside, CH5 2UA, is a leading molecular diagnostics company that specializes in the development and manufacture of innovative diagnostic products Founded in 2008, Biofortuna has quickly established itself as a key player in the field of personalized medicine, providing high-quality molecular diagnostic solutions to healthcare professionals around the world.
The company’s state-of-the-art facilities in Deeside are equipped with the latest technologies and staffed by a team of experienced scientists and technicians who are dedicated to driving innovation and excellence in the field of molecular diagnostics Biofortuna’s commitment to quality and scientific rigor has earned it a reputation as a trusted partner for healthcare providers seeking accurate and reliable diagnostic tests.
One of Biofortuna’s core areas of expertise is in the development of custom assay solutions for a wide range of applications, including infectious disease testing, transplant diagnostics, and pharmacogenomics The company’s innovative technologies enable rapid and accurate detection of genetic variations that can impact patient outcomes, allowing healthcare providers to make informed treatment decisions that are tailored to each individual’s unique genetic profile.
In addition to its custom assay development services, Biofortuna also offers a range of off-the-shelf diagnostic products, including the popular SSPGo® range of HLA typing kits These kits are designed to streamline the process of determining tissue compatibility for transplant patients, helping to improve outcomes for patients in need of life-saving organ transplants.
Biofortuna is also a pioneer in the field of freeze-dried molecular diagnostics, with its proprietary technology allowing for the stable storage and transportation of diagnostic tests without the need for refrigeration This revolutionary approach to diagnostic testing has significant implications for global healthcare, particularly in resource-limited settings where access to reliable refrigeration may be limited.
As a socially responsible company, Biofortuna is committed to making a positive impact on global health through its innovative diagnostic solutions “Biofortuna Limited, 2 Tenth Avenue, Deeside Industrial Park, Deeside, CH5 2UA. The company works closely with healthcare providers and researchers to develop new diagnostic tests that address unmet medical needs and improve patient outcomes By leveraging the power of molecular diagnostics, Biofortuna is helping to pave the way for more personalized and effective healthcare interventions.
In recognition of its dedication to excellence in molecular diagnostics, Biofortuna has received numerous awards and accolades, including the Queen’s Award for Enterprise in Innovation This prestigious award is a testament to the company’s commitment to driving innovation in the field of personalized medicine and its impact on improving patient outcomes.
Furthermore, Biofortuna’s commitment to quality and innovation is reflected in its ISO 13485 certification, which ensures that the company’s products meet the highest standards of quality and safety This certification is a mark of excellence in the medical device industry and demonstrates Biofortuna’s ongoing commitment to delivering reliable and accurate diagnostic solutions to its customers.
In conclusion, Biofortuna Limited, located at 2 Tenth Avenue, Deeside Industrial Park, Deeside, CH5 2UA, is a leading molecular diagnostics company that is dedicated to driving innovation and excellence in the field of personalized medicine With its state-of-the-art facilities, experienced team of scientists and technicians, and commitment to quality and innovation, Biofortuna is well-positioned to continue making a significant impact on global health through its innovative diagnostic solutions.